Distribuzione geografica
Continente #
NA - Nord America 450
EU - Europa 288
AS - Asia 83
OC - Oceania 12
SA - Sud America 10
AF - Africa 1
Totale 844
Nazione #
US - Stati Uniti d'America 428
GB - Regno Unito 120
IT - Italia 72
DE - Germania 26
IN - India 25
CA - Canada 20
CZ - Repubblica Ceca 19
FR - Francia 14
TR - Turchia 14
AU - Australia 12
CN - Cina 12
JP - Giappone 12
BR - Brasile 7
FI - Finlandia 5
RO - Romania 4
SA - Arabia Saudita 4
SG - Singapore 4
AT - Austria 3
ES - Italia 3
GR - Grecia 3
HK - Hong Kong 3
NL - Olanda 3
RU - Federazione Russa 3
BE - Belgio 2
CL - Cile 2
IL - Israele 2
LV - Lettonia 2
RS - Serbia 2
AM - Armenia 1
BY - Bielorussia 1
CH - Svizzera 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
KW - Kuwait 1
MD - Moldavia 1
MS - Montserrat 1
MX - Messico 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SE - Svezia 1
UA - Ucraina 1
YE - Yemen 1
ZA - Sudafrica 1
Totale 844
Città #
Ashburn 208
London 114
San Francisco 32
Rome 27
Toronto 20
Boardman 19
Brno 18
Council Bluffs 18
Pune 18
Redmond 16
Washington 15
Seattle 14
Los Angeles 10
Munich 9
Canberra 6
Helsinki 5
Melbourne 5
Paris 5
Riyadh 4
São Paulo 4
West Jordan 4
Athens 3
Durham 3
Naples 3
Ningbo 3
Oklahoma City 3
Padova 3
Shanghai 3
Singapore 3
Tokyo 3
Vienna 3
Amsterdam 2
Ankara 2
Anyang 2
Caluire-et-Cuire 2
Charlotte 2
Ferrara di Monte Baldo 2
Haikou 2
Hong Kong 2
Hyderabad 2
Kragujevac 2
Lyon 2
Madrid 2
New York 2
Parma 2
Riga 2
Santa Clara 2
Scafati 2
Yuncheng 2
Agordo 1
Amman 1
Bari 1
Berlin 1
Brussels 1
Budapest 1
Cagliari 1
Centurion 1
Charleston 1
Chisinau 1
Costabissara 1
Dalsjoefors 1
Dorchester 1
Ferrara 1
Forest City 1
Frankfurt am Main 1
Haifa 1
Hanover 1
Krasnoyarsk 1
Kuwait City 1
Lancaster 1
Lima 1
Lincoln 1
Macerata 1
Manassas 1
Manila 1
Martignacco 1
Messina 1
Mexico City 1
Miami 1
Minsk 1
Morgantown 1
Mumbai 1
Paola 1
Parkville 1
Phoenix 1
Piemonte 1
Porto 1
Prague 1
Puchong Batu Dua Belas 1
Redwood City 1
San Pietro in Lama 1
Sanaa 1
Sant'Elena 1
Satu Mare 1
Secaucus 1
Selidovo 1
Sydney 1
Yerevan 1
Totale 686
Nome #
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 29
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 17
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma 14
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 13
Biological effects of cabozantinib on bone microenvironment 13
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential 13
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 12
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 12
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 11
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 11
Molecular prognostic factors in patients with pancreatic cancer 11
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge 11
Integrin alpha-5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions 11
Natural history of skeletal disease in primary biliary cancers. National survey on behalf of GICO group (Gruppo Italiano Colangiocarcinoma – Onlus) 11
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 11
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 11
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 10
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 10
New developments of aminobisphosphonates: the double face of Janus 10
Bone Health in Cancer Patients 10
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins 10
Role of glyoxalase-1 in trabectedin-resistant myxoid liposarcoma 10
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 10
Dicer and Drosha Expression and Response to Bevacizumab-Based Therapy in Advanced Colorectal Cancer Patients 10
Bone metastases in biliary cancers: A multicenter retrospective survey 9
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 9
Premetastatic niche: ready for new therapeutic interventions? 9
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 9
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 9
Facing SARS-CoV-2 outbreak in immunotherapy era 9
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 9
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 9
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 9
M1-polarized macrophages as predictor of poor response to trabectedin treatment in myxoid liposarcoma 9
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment 8
Interventional radiologist's perspective on the management of bone metastatic disease 8
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 8
Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients 8
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 8
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 8
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 8
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 8
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 8
Anterior and posterior vaginal myomectomy: A new surgical technique 7
Tissue invasion and metastasis: Molecular, biological and clinical perspectives. 7
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 7
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 7
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 7
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 7
Denosumab for cancer-related bone loss 7
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis 7
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 7
Osteoporosis 2014 7
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms 7
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 6
Targeting bone metastases starting from the preneoplastic niche: home sweet home 6
Magnesium: are we better off without it? 6
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 6
Current and Emerging Biomarkers Predicting Bone Metastasis Development 6
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7) 6
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 6
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 6
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker? 6
The role of bone microenvironment, vitamin D and calcium 6
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial 6
Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey 6
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 6
Effect of cholesterol and triglyceride increases on time to progression in renal clear cell cancer patients treated with everolimus 6
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 6
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 6
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 6
Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors 6
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis 5
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer 5
Determinants of bone specific metastasis in prostate cancer 5
COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management 5
Development of a new clinical nomogram including velocity rate of disease progression to predict outcome in metastatic colorectal cancer patients treated with bevacizumab beyond progression: A subanalysis from tribe trial 5
Dynamic changes of receptor activator of nuclear factor-κB expression in circulating tumor cells during denosumab predict treatment effectiveness in metastatic breast cancer 5
Stevens-Johnson syndrome associated with reduced tear production complicating the use of cetuximab and panitunumab 5
Novel Biomarkers predicting the development of bone metastasis in Early Breast Cancer 5
Oncologia 5
Bone-Targeted Agents 5
New molecular targets in bone metastases 5
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives 5
Natural history of malignant bone disease in gastric cancer: Final results of a multicenter bone metastasis survey 5
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma 5
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in angiosarcoma and leiomyosarcoma 5
Natural history of malignant bone disease in non-small cell lung cancer: Preliminary results of a multicenter bone metastasis survey 5
miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes 5
Effects of cabozantinib on bone turnover markers in patients with metastatic renal cell carcinoma 5
Clinical outcomes of metastatic renal carcinoma following disease progression to programmed death (PD)-1 or PD-L1 inhibitors (I-O): A Meet-URO group real-world study (Meet-Uro 7) 5
Serum Plasma Leptin Levels and Life Expectancy in Cancer Patients with Terminal Illness 5
Prognostic value of systemic inflammatory biomarkers in patients with mCRPC treated with abiraterone in pre-docetaxel setting 5
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials 5
Circulating Tumor Cells in Soft Tissue Sarcomas Patients 5
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 4
Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis 4
Response to cabozantinib in renal cell carcinoma with cardiac metastases 4
Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer 4
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients 4
Totale 773
Categoria #
all - tutte 31.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.795

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022332 0 0 9 1 89 4 8 1 12 1 4 203
2022/202366 2 1 0 1 6 3 7 15 1 3 24 3
2023/2024524 16 50 31 31 51 231 7 20 8 24 18 37
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 937